Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chien-Ju Lin

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
JMIR Research Protocols|August 6, 2025
A Dashboard for Managing an Ecosystem and People With Dementia: Protocol for a Healthy Ageing Ecosystem for People With Dementia (HAAL) International Feasibility Pilot StudyGiulio Amabili, Elvira Maranesi, Federico Barbarossa, et al.
JMIR Research Protocols|May 8, 2026
Authors' Reply: Posttrial Withdrawal Ethics in the Healthy Ageing Ecosystem for People With Dementia (HAAL) StudyGiulio Amabili, Elvira Maranesi, Federico Barbarossa, et al.
Frontiers in Pharmacology|December 12, 2022
Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidationDe-Shan Ning, Yu-Ju Chen, Chien-Ju Lin, et al.
Environmental and Molecular Mutagenesis|July 12, 2008
Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 miceMugimane G Manjanatha, Sharon D Shelton, Vasily N Dobrovolsky, et al.
BMC Genomics|June 2, 2007
Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling schemeLi-Jen Su, Ching-Wei Chang, Yu-Chung Wu, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trialsTobias Derfuss, Robert Bermel, Chien-Ju Lin, et al.
International Journal of Environmental Research and Public Health|February 26, 2020
The Association between Metabolically Healthy Obesity, Cardiovascular Disease, and All-Cause Mortality Risk in Asia: A Systematic Review and Meta-AnalysisMing-Yuan Huang, Mu-Yi Wang, Yu-Sheng Lin, et al.
Journal of Neurology|January 15, 2025
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I studySoe Mar, Massimiliano Valeriani, Barbara Steinborn, et al.
Mutation Research|January 13, 2009
The genetic toxicology of methylphenidate hydrochloride in non-human primatesSuzanne M Morris, Vasily N Dobrovolsky, Joseph G Shaddock, et al.
Frontiers in Dementia|July 31, 2024
The evaluation of a decision support system integrating assistive technology for people with dementia at homeHenk Herman Nap, Nathalie E Stolwijk, Sima Ipakchian Askari, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
JMIR Research Protocols|August 6, 2025
A Dashboard for Managing an Ecosystem and People With Dementia: Protocol for a Healthy Ageing Ecosystem for People With Dementia (HAAL) International Feasibility Pilot StudyGiulio Amabili, Elvira Maranesi, Federico Barbarossa, et al.
JMIR Research Protocols|May 8, 2026
Authors' Reply: Posttrial Withdrawal Ethics in the Healthy Ageing Ecosystem for People With Dementia (HAAL) StudyGiulio Amabili, Elvira Maranesi, Federico Barbarossa, et al.
Frontiers in Pharmacology|December 12, 2022
Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidationDe-Shan Ning, Yu-Ju Chen, Chien-Ju Lin, et al.
Environmental and Molecular Mutagenesis|July 12, 2008
Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 miceMugimane G Manjanatha, Sharon D Shelton, Vasily N Dobrovolsky, et al.
BMC Genomics|June 2, 2007
Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling schemeLi-Jen Su, Ching-Wei Chang, Yu-Chung Wu, et al.
Therapeutic Advances in Neurological Disorders|October 14, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trialsTobias Derfuss, Robert Bermel, Chien-Ju Lin, et al.
International Journal of Environmental Research and Public Health|February 26, 2020
The Association between Metabolically Healthy Obesity, Cardiovascular Disease, and All-Cause Mortality Risk in Asia: A Systematic Review and Meta-AnalysisMing-Yuan Huang, Mu-Yi Wang, Yu-Sheng Lin, et al.
Journal of Neurology|January 15, 2025
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I studySoe Mar, Massimiliano Valeriani, Barbara Steinborn, et al.
Mutation Research|January 13, 2009
The genetic toxicology of methylphenidate hydrochloride in non-human primatesSuzanne M Morris, Vasily N Dobrovolsky, Joseph G Shaddock, et al.
Frontiers in Dementia|July 31, 2024
The evaluation of a decision support system integrating assistive technology for people with dementia at homeHenk Herman Nap, Nathalie E Stolwijk, Sima Ipakchian Askari, et al.
Pageof 12